Global Tumor Embolization Market Size, Status and Forecast 2024-2031

Report ID: 921825 | Published Date: Mar 2026 | No. of Page: 87 | Base Year: 2025 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Tumor Embolization Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Trans-Arterial Embolization (TAE)
        1.2.3 Drug-Eluting Bead Chemoembolization (DEB-TACE)
        1.2.4 Radioembolization (RE)
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Tumor Embolization Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Specialty Clinics
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Tumor Embolization Market Perspective (2016-2027)
    2.2 Tumor Embolization Growth Trends by Regions
        2.2.1 Tumor Embolization Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Tumor Embolization Historic Market Share by Regions (2016-2021)
        2.2.3 Tumor Embolization Forecasted Market Size by Regions (2022-2027)
    2.3 Tumor Embolization Industry Dynamic
        2.3.1 Tumor Embolization Market Trends
        2.3.2 Tumor Embolization Market Drivers
        2.3.3 Tumor Embolization Market Challenges
        2.3.4 Tumor Embolization Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Tumor Embolization Players by Revenue
        3.1.1 Global Top Tumor Embolization Players by Revenue (2016-2021)
        3.1.2 Global Tumor Embolization Revenue Market Share by Players (2016-2021)
    3.2 Global Tumor Embolization Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Tumor Embolization Revenue
    3.4 Global Tumor Embolization Market Concentration Ratio
        3.4.1 Global Tumor Embolization Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Tumor Embolization Revenue in 2020
    3.5 Tumor Embolization Key Players Head office and Area Served
    3.6 Key Players Tumor Embolization Product Solution and Service
    3.7 Date of Enter into Tumor Embolization Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Tumor Embolization Breakdown Data by Type
    4.1 Global Tumor Embolization Historic Market Size by Type (2016-2021)
    4.2 Global Tumor Embolization Forecasted Market Size by Type (2022-2027)

5 Tumor Embolization Breakdown Data by Application
    5.1 Global Tumor Embolization Historic Market Size by Application (2016-2021)
    5.2 Global Tumor Embolization Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Tumor Embolization Market Size (2016-2027)
    6.2 North America Tumor Embolization Market Size by Type
        6.2.1 North America Tumor Embolization Market Size by Type (2016-2021)
        6.2.2 North America Tumor Embolization Market Size by Type (2022-2027)
        6.2.3 North America Tumor Embolization Market Size by Type (2016-2027)
    6.3 North America Tumor Embolization Market Size by Application
        6.3.1 North America Tumor Embolization Market Size by Application (2016-2021)
        6.3.2 North America Tumor Embolization Market Size by Application (2022-2027)
        6.3.3 North America Tumor Embolization Market Size by Application (2016-2027)
    6.4 North America Tumor Embolization Market Size by Country
        6.4.1 North America Tumor Embolization Market Size by Country (2016-2021)
        6.4.2 North America Tumor Embolization Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Tumor Embolization Market Size (2016-2027)
    7.2 Europe Tumor Embolization Market Size by Type
        7.2.1 Europe Tumor Embolization Market Size by Type (2016-2021)
        7.2.2 Europe Tumor Embolization Market Size by Type (2022-2027)
        7.2.3 Europe Tumor Embolization Market Size by Type (2016-2027)
    7.3 Europe Tumor Embolization Market Size by Application
        7.3.1 Europe Tumor Embolization Market Size by Application (2016-2021)
        7.3.2 Europe Tumor Embolization Market Size by Application (2022-2027)
        7.3.3 Europe Tumor Embolization Market Size by Application (2016-2027)
    7.4 Europe Tumor Embolization Market Size by Country
        7.4.1 Europe Tumor Embolization Market Size by Country (2016-2021)
        7.4.2 Europe Tumor Embolization Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Tumor Embolization Market Size (2016-2027)
    8.2 Asia-Pacific Tumor Embolization Market Size by Type
        8.2.1 Asia-Pacific Tumor Embolization Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Tumor Embolization Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Tumor Embolization Market Size by Type (2016-2027)
    8.3 Asia-Pacific Tumor Embolization Market Size by Application
        8.3.1 Asia-Pacific Tumor Embolization Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Tumor Embolization Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Tumor Embolization Market Size by Application (2016-2027)
    8.4 Asia-Pacific Tumor Embolization Market Size by Region
        8.4.1 Asia-Pacific Tumor Embolization Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Tumor Embolization Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Tumor Embolization Market Size (2016-2027)
    9.2 Latin America Tumor Embolization Market Size by Type
        9.2.1 Latin America Tumor Embolization Market Size by Type (2016-2021)
        9.2.2 Latin America Tumor Embolization Market Size by Type (2022-2027)
        9.2.3 Latin America Tumor Embolization Market Size by Type (2016-2027)
    9.3 Latin America Tumor Embolization Market Size by Application
        9.3.1 Latin America Tumor Embolization Market Size by Application (2016-2021)
        9.3.2 Latin America Tumor Embolization Market Size by Application (2022-2027)
        9.3.3 Latin America Tumor Embolization Market Size by Application (2016-2027)
    9.4 Latin America Tumor Embolization Market Size by Country
        9.4.1 Latin America Tumor Embolization Market Size by Country (2016-2021)
        9.4.2 Latin America Tumor Embolization Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Tumor Embolization Market Size (2016-2027)
    10.2 Middle East & Africa Tumor Embolization Market Size by Type
        10.2.1 Middle East & Africa Tumor Embolization Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Tumor Embolization Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Tumor Embolization Market Size by Type (2016-2027)
    10.3 Middle East & Africa Tumor Embolization Market Size by Application
        10.3.1 Middle East & Africa Tumor Embolization Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Tumor Embolization Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Tumor Embolization Market Size by Application (2016-2027)
    10.4 Middle East & Africa Tumor Embolization Market Size by Country
        10.4.1 Middle East & Africa Tumor Embolization Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Tumor Embolization Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Boston Scientific Corporation
        11.1.1 Boston Scientific Corporation Company Details
        11.1.2 Boston Scientific Corporation Business Overview
        11.1.3 Boston Scientific Corporation Tumor Embolization Introduction
        11.1.4 Boston Scientific Corporation Revenue in Tumor Embolization Business (2016-2021)
        11.1.5 Boston Scientific Corporation Recent Development
    11.2 Varian Medical Systems, Inc.
        11.2.1 Varian Medical Systems, Inc. Company Details
        11.2.2 Varian Medical Systems, Inc. Business Overview
        11.2.3 Varian Medical Systems, Inc. Tumor Embolization Introduction
        11.2.4 Varian Medical Systems, Inc. Revenue in Tumor Embolization Business (2016-2021)
        11.2.5 Varian Medical Systems, Inc. Recent Development
    11.3 Nordion (Sotera Health)
        11.3.1 Nordion (Sotera Health) Company Details
        11.3.2 Nordion (Sotera Health) Business Overview
        11.3.3 Nordion (Sotera Health) Tumor Embolization Introduction
        11.3.4 Nordion (Sotera Health) Revenue in Tumor Embolization Business (2016-2021)
        11.3.5 Nordion (Sotera Health) Recent Development
    11.4 Sirtex Medical
        11.4.1 Sirtex Medical Company Details
        11.4.2 Sirtex Medical Business Overview
        11.4.3 Sirtex Medical Tumor Embolization Introduction
        11.4.4 Sirtex Medical Revenue in Tumor Embolization Business (2016-2021)
        11.4.5 Sirtex Medical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Tumor Embolization Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Trans-Arterial Embolization (TAE)
    Table 3. Key Players of Drug-Eluting Bead Chemoembolization (DEB-TACE)
    Table 4. Key Players of Radioembolization (RE)
    Table 5. Key Players of Others
    Table 6. Global Tumor Embolization Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Tumor Embolization Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Tumor Embolization Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Tumor Embolization Market Share by Regions (2016-2021)
    Table 10. Global Tumor Embolization Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Tumor Embolization Market Share by Regions (2022-2027)
    Table 12. Tumor Embolization Market Trends
    Table 13. Tumor Embolization Market Drivers
    Table 14. Tumor Embolization Market Challenges
    Table 15. Tumor Embolization Market Restraints
    Table 16. Global Tumor Embolization Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Tumor Embolization Market Share by Players (2016-2021)
    Table 18. Global Top Tumor Embolization Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Embolization as of 2020)
    Table 19. Ranking of Global Top Tumor Embolization Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Tumor Embolization Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Tumor Embolization Product Solution and Service
    Table 23. Date of Enter into Tumor Embolization Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Tumor Embolization Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Tumor Embolization Revenue Market Share by Type (2016-2021)
    Table 27. Global Tumor Embolization Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Tumor Embolization Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Tumor Embolization Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Tumor Embolization Revenue Market Share by Application (2016-2021)
    Table 31. Global Tumor Embolization Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Tumor Embolization Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Tumor Embolization Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Tumor Embolization Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Tumor Embolization Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Tumor Embolization Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Tumor Embolization Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Tumor Embolization Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Tumor Embolization Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Tumor Embolization Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Tumor Embolization Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Tumor Embolization Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Tumor Embolization Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Tumor Embolization Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Tumor Embolization Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Tumor Embolization Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Tumor Embolization Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Tumor Embolization Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Tumor Embolization Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Tumor Embolization Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Tumor Embolization Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Tumor Embolization Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Tumor Embolization Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Tumor Embolization Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Tumor Embolization Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Tumor Embolization Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Tumor Embolization Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Tumor Embolization Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Tumor Embolization Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Tumor Embolization Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Tumor Embolization Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Tumor Embolization Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Boston Scientific Corporation Company Details
    Table 64. Boston Scientific Corporation Business Overview
    Table 65. Boston Scientific Corporation Tumor Embolization Product
    Table 66. Boston Scientific Corporation Revenue in Tumor Embolization Business (2016-2021) & (US$ Million)
    Table 67. Boston Scientific Corporation Recent Development
    Table 68. Varian Medical Systems, Inc. Company Details
    Table 69. Varian Medical Systems, Inc. Business Overview
    Table 70. Varian Medical Systems, Inc. Tumor Embolization Product
    Table 71. Varian Medical Systems, Inc. Revenue in Tumor Embolization Business (2016-2021) & (US$ Million)
    Table 72. Varian Medical Systems, Inc. Recent Development
    Table 73. Nordion (Sotera Health) Company Details
    Table 74. Nordion (Sotera Health) Business Overview
    Table 75. Nordion (Sotera Health) Tumor Embolization Product
    Table 76. Nordion (Sotera Health) Revenue in Tumor Embolization Business (2016-2021) & (US$ Million)
    Table 77. Nordion (Sotera Health) Recent Development
    Table 78. Sirtex Medical Company Details
    Table 79. Sirtex Medical Business Overview
    Table 80. Sirtex Medical Tumor Embolization Product
    Table 81. Sirtex Medical Revenue in Tumor Embolization Business (2016-2021) & (US$ Million)
    Table 82. Sirtex Medical Recent Development
    Table 83. Research Programs/Design for This Report
    Table 84. Key Data Information from Secondary Sources
    Table 85. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Tumor Embolization Market Share by Type: 2020 VS 2027
    Figure 2. Trans-Arterial Embolization (TAE) Features
    Figure 3. Drug-Eluting Bead Chemoembolization (DEB-TACE) Features
    Figure 4. Radioembolization (RE) Features
    Figure 5. Others Features
    Figure 6. Global Tumor Embolization Market Share by Application: 2020 VS 2027
    Figure 7. Hospitals Case Studies
    Figure 8. Ambulatory Surgical Centers Case Studies
    Figure 9. Specialty Clinics Case Studies
    Figure 10. Others Case Studies
    Figure 11. Tumor Embolization Report Years Considered
    Figure 12. Global Tumor Embolization Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Tumor Embolization Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Tumor Embolization Market Share by Regions: 2020 VS 2027
    Figure 15. Global Tumor Embolization Market Share by Regions (2022-2027)
    Figure 16. Global Tumor Embolization Market Share by Players in 2020
    Figure 17. Global Top Tumor Embolization Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Embolization as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Tumor Embolization Revenue in 2020
    Figure 19. Global Tumor Embolization Revenue Market Share by Type (2016-2021)
    Figure 20. Global Tumor Embolization Revenue Market Share by Type (2022-2027)
    Figure 21. North America Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Tumor Embolization Market Share by Type (2016-2027)
    Figure 23. North America Tumor Embolization Market Share by Application (2016-2027)
    Figure 24. North America Tumor Embolization Market Share by Country (2016-2027)
    Figure 25. United States Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Tumor Embolization Market Share by Type (2016-2027)
    Figure 29. Europe Tumor Embolization Market Share by Application (2016-2027)
    Figure 30. Europe Tumor Embolization Market Share by Country (2016-2027)
    Figure 31. Germany Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Tumor Embolization Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Tumor Embolization Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Tumor Embolization Market Share by Region (2016-2027)
    Figure 41. China Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Tumor Embolization Market Share by Type (2016-2027)
    Figure 49. Latin America Tumor Embolization Market Share by Application (2016-2027)
    Figure 50. Latin America Tumor Embolization Market Share by Country (2016-2027)
    Figure 51. Mexico Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Tumor Embolization Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Tumor Embolization Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Tumor Embolization Market Share by Country (2016-2027)
    Figure 57. Turkey Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Tumor Embolization Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Boston Scientific Corporation Revenue Growth Rate in Tumor Embolization Business (2016-2021)
    Figure 61. Varian Medical Systems, Inc. Revenue Growth Rate in Tumor Embolization Business (2016-2021)
    Figure 62. Nordion (Sotera Health) Revenue Growth Rate in Tumor Embolization Business (2016-2021)
    Figure 63. Sirtex Medical Revenue Growth Rate in Tumor Embolization Business (2016-2021)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Boston Scientific Corporation
Varian Medical Systems, Inc.
Nordion (Sotera Health)
Sirtex Medical
Frequently Asked Questions
Tumor Embolization report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Tumor Embolization report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Tumor Embolization report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports